Last updated: 2026-10-11 16:25:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
electroCore, Inc. (ECOR) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.62, with a market capitalization of $87.09M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.41 to $12.70. This page covers its latest market performance, valuation, price trends and company information.
$87.09M | |
$9.37 | |
$303.45 | |
$2.92 | |
$9.51 | |
42.26K | |
81.53K | |
-- | |
$12.70 | |
$4.41 | |
-- | |
-- |
electroCore, Inc. (ECOR) last closed at $9.51 as of 2026-10-09 19:59:03, unchanged from the previous close of $9.51.
During the latest regular trading session, ECOR traded between $2.92 and $303.45, with a volume of 42.26K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, electroCore, Inc. (ECOR) moved from $10.32 to $9.62, representing a decline of 6.74% ($0.70).
The stock traded between $9.25 and $11.08 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 62.51 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 62.8%
ECOR is currently trading at $9.62, placing it 62.8% of the way from its 52-week low of $4.41 to its 52-week high of $12.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 83 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of electroCore, Inc. (ECOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.